Genmab | GEN - Выручка от реализации





Продажи Изменить Дата
Agios Pharmaceuticals USD 55.38M 10.64M 2026-09
Almirall EUR 602.71M 55.09M 2026-06
Amarin USD 49.22M 451K 2025-12
Amgen USD 10.4B 300M 2026-09
argenx SE USD 1.72B 361M 2026-09
AstraZeneca USD 16.21B 830M 2026-09
Bayer EUR 10.05B 820M 2026-09
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
Demant DKK 6.67B 420M 2026-06
Exelixis USD 658.69M 30M 2026-09
Fresenius Medical Care EUR 4.94B 80M 2026-09
Genmab DKK 1.16B 259M 2026-06
GlaxoSmithKline GBP 8.89B 480M 2026-09
GN Store Nord DKK 2.27B 100M 2026-09
GRIFOLS EUR 2.04B 170M 2026-09
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Insmed USD 524.42M 98.93M 2026-09
Lakefront Biotherapeutics EUR 7.11M 5M 2026-09
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.63B 200M 2026-09
Novartis USD 14.52B 112M 2026-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 14.44B 2.49B 2026-09
UCB EUR 4.25B 764M 2025-12